Valacyclovir prophylaxis to prevent recurrent herpes at delivery: A randomized clinical trial

Obstetrics and Gynecology

Volumn 108, Issue 1, 2006, Pages 141-147

  Sheffield, Jeanne S ^a,b   Hill, James B ^a   Hollier, Lisa M ^a   Laibl, Vanessa R ^a   Roberts, Scott W ^a   Sanchez, Pablo J ^a   Wendel Jr , George D ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VALACICLOVIR; ACICLOVIR; ANTIVIRUS AGENT; DRUG DERIVATIVE; VALINE; VIRUS DNA;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; GENITAL HERPES; HERPES SIMPLEX VIRUS; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; THIRD TRIMESTER PREGNANCY; VIRUS CULTURE; DELIVERY; DISEASE TRANSMISSION; HERPES SIMPLEX VIRUS 2; ISOLATION AND PURIFICATION; NEWBORN; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMEDICATION; PROSPECTIVE STUDY;

ACYCLOVIR; ANTIVIRAL AGENTS; CESAREAN SECTION; DELIVERY, OBSTETRIC; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; DOUBLE-BLIND METHOD; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREMEDICATION; PROSPECTIVE STUDIES; RECURRENCE; VALINE;

EID: 33746930873     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000219749.96274.15     Document Type: Article

References (28)

1. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK, et al. Herpes simplex virus type 2 in the United States, 1976-1994. N Engl J Med 1997;337:1105-11.
2. Corey L, Handsfield HH. Genital herpes and public health: addressing a global problem. JAMA 2000;283:791-4.
3. Brown ZA, Benedetti JK, Watts DH, Selke S, Berry S, Ashley RL, et al. A comparison between detailed and simple histories in the diagnosis of genital herpes complicating pregnancy. Am J Obstet Gynecol 1995;172:1299-303.
4. Prober CG, Corey L, Brown ZA, Hensleigh PA, Frenkel LM, Bryson YJ, et al. The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis 1992;15:1031-8.
5. Armstrong GL, Schillinger J, Markowitz L, Nahmias AJ, Johnson RE, McQuillan GM, et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol 2001;153:912-20.
6. De Schryver A, Meheus A. Epidemiology of sexually transmitted diseases: the global picture. Bull World Health Organ 1990;68:639-54.
7. Whitley RJ. Herpes simplex virus infections of women and their offspring: implications for a developed society. Proc Natl Acad Sci U S A 1994;91:2441-7.
8. American College of Obstetricians and Gynecologists. Management of herpes in pregnancy. ACOG Practice Bulletin 8. Washington, DC: ACOG; 1999.
9. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995;333:770-5.
10. Arvin AM, Prober CG. Herpes simplex virus infections. Pediatr Infect Dis J 1990;9:765-7.
11. Braig S, Luton D, Sibony O, Edlinger C, Boissinot C, Blot P, et al. Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding. Eur J Obstet Gynecol Reprod Biol 2001;96:55-8.
12. Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
13. Brown ZA, Benedetti J, Ashley R, Burchett S, Selke S, Berry S, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991;324:1247-52.
14. Whitley R, Arvin A, Prober C, Corey L, Burchett S, Plotkin S, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Disease Collaborative Antiviral Study Group. N Engl J Med 1991;324:450-4.
15. Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery; a systematic review. Obstet Gynecol 2003;102:1396-403.
16. Weller S, Blum M, Doucette M, Burnette T, Cederberg DM, de Miranda P, et al. Pharmacokinetics of acyclovir pro-drug valacyclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 1993;54:595-605.
17. Conant MA, Schacker TW, Murphy RL, Gold J, Crutchfield LT, Crooks RJ, et al. Valacyclovir versus acyclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials. Int J STD AIDS 2002;13:12-21.
18. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350:11-20.
19. Baker DA, Blythe JG, Miller JM. Once-daily valacyclovir hydrochloride for suppression of recurrent genital herpes. Obstet Gynecol 1999;94:103-6.
20. Reitano M, Tyring S, Lang W, Thoming C, Worm A-M, Borelli S, et al. Valacyclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valacyclovir HSV Study Group. J Infect Dis 1998;178:603-10.
21. Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Corey L, Gruber WC, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001;108:230-8.
22. Kimberlin D, Powell D, Gruber W, Diaz P, Arvin A, Kumar M, et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J 1996;15:247-54.
23. Bai X, Rogers BB, Harkins PC, Sommerauer J, Squires R, Rotondo K, et al. Predictive value of quantitative PCR-based viral burden analysis for eight human herpesviruses in pediatric solid organ transplant patients. J Mol Diagn 2000;2:191-201.
24. Bai X, Hosler G, Rogers BB, Dawson DB, Scheuermann RH. Quantitative polymerase chain reaction for human herpesvirus diagnosis and measurement of Epstein-Barr virus burden in posttransplant lymphoproliferative disorder. Clin Chem 1997;43:1843-9.
25. Hoang MP, Rogers BB, Dawson DB, Scheuermann RH. Quantitation of 8 human herpesviruses in peripheral blood of human immunodeficiency virus-infected patients and healthy blood donors by polymerase chain reaction. Am J Clin Pathol 1999;111:655-9.
26. Division of AIDS table for grading the severity of adult and pediatric adverse events. December 2004. Available at: http://rcc.tech-res.com/tox_tables. htm. Retrieved January 3, 2006.
27. Gupta R, Krantz E, Selke S, Warren T, Vargas-Cortes M, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis 2004;190:1374-81.
28. Weller S, Blum MR, Doucette M, Burnette T, Cederberg DM, de Miranda P, et al. Pharmacokinetics of the acyclovir prodrug valacyclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 1993;54:595-605.